Peer Review History

Original SubmissionOctober 3, 2021
Decision Letter - Gerardo Chowell, Editor, Nina H. Fefferman, Editor

Dear Mr. Zhao,

Thank you very much for submitting your manuscript "Characterizing superspreading potential of infectious disease: Decomposition of individual transmissibility" for consideration at PLOS Computational Biology.

As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

Both Reviewers have raised excellent points that should be helpful to the authors to strengthen their work.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Gerardo Chowell, PhD

Guest Editor

PLOS Computational Biology

Nina Fefferman

Deputy Editor

PLOS Computational Biology

***********************

Both Reviewers have raised excellent points that should be helpful to the authors to strengthen their work.

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: Please see the attachment.

Reviewer #2: This paper provides an interesting viewpoint on the potential use of Delaporte distribution for the offspring distribution as an extended alternative to the negative-binomial distribution. The explanation of the methods is clear and well supported. Inclusion of not only offspring distribution data but also single-generation and final cluster size data is very useful. Moreover, some of the study findings, including that the temporal change in South Korean data is explained by the change in the R_F/R_V proportion (rho), not in k, are of epidemiological interest. This may bring a new insight into how we may understand the offspring distribution from outbreaks under interventions.

Overall I feel the manuscript is of good quality and do not have much major criticism. Meanwhile, I would like to list two suggestions which I believe could further improve the epidemiological relevance of this paper; if the authors believe these do not make enough sense or involve overwhelming amount of additional effort (which is not what I wish to impose), I would be happy to be convinced.

- While some may adopt the Delaporte distribution for characterizing the offspring distribution, I expect that the majority of studies might continue to use the negative-binomial distribution (because it’s more mathematically convenient). In that case, it might be important to ensure that the interpretation of the estimates from these distributions are reasonably linked. Specifically, a study may fit a negative binomial distribution to a dataset (let’s call it dataset A) which is actually better represented by a Delaporte distribution, and report estimates for negative-binomial R and k. If one wishes to analyse another dataset (dataset B) using a Delaporte distribution and compare the results with these estimates, it would be convenient to have a measure that quantifies the similarity between a negative-binomial and a Delaporte distribution. For example, the estimated distributions in Figure 5 are more or less very similar between the NB and Delaporte, however their estimates are very different (because they represent different quantities). If the Delaporte distribution is close enough to a negative binomial distribution, NB might be a practical choice to ensure comparability and/or mathematical convenience (even if AIC suggests Delaporte is preferred). It would be therefore nice to have the following statistics given the Delaporte parameters R_F, R_V, and k : (1) estimators for R and k of a negative distribution that is the most similar to the given Delaporte distribution; (2) a measure of the similarity between the Delarporte distribution and the negative distribution given by (1), or conditions for the NB approximation to work well. However, these may not be easily obtained from the Delaporte estimates (e.g., require nonlinear optimization), in which case I would not request it as strongly.

- If there is an appropriate dataset available, I would wish to see an application example of the Delaporte distribution to the final outbreak size c, in addition to the currently included offspring distribution data (e.g., what correspond to Fig 5 and Table 1).

Minor comments

- L122 addictive -> additive?

- L124 I believe the individual reproduction number here is rather a non-standard usage (e.g. see https:doi.org/10.1371/journal.pone.0000758) and thus I feel this needs to be redefined/explained.

- L163–4 can you add a bit more context such that it’s clear in what way the interpretation of k is consistent with NB?

- L176 I believe ⌊∙⌋ is the floor function, not rounding (and the floor function should be used here).

- Section 2.4: In this setting I believe AIC and LR test are equivalent (difference of 2 in AIC corresponds to p = 0.05 in LR test) and including both seems redundant (and AIC is more widely used because it’s a more general framework). Could the same conclusion be obtained if the AIC-based model selection was used in place of LR for the discussion of type I/II errors?

- L315 It -> It is?

- L354–357 This is an important point. Can you briefly mention where the assumption of R<1 was introduced (L334) that this assumption would be relaxed in the end? Otherwise the reader may misinterpret that the final cluster size likelihood can only be used for R<1.

- Figures: there are an overwhelming number of figures (with even many panels). Some of them may better fit in the supplementary file.

- Throughout, I suggest the authors always distinguish between one-generation cluster size and final outbreak size and try to avoid just saying “cluster size” or “outbreak size” for best clarity.

- I found some typos/grammatical errors in the manuscript (which I named above) and I suggest the authors proofread the manuscript once again.

**********

Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: None

Reviewer #2: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Attachments
Attachment
Submitted filename: superspreading.pdf
Revision 1

Attachments
Attachment
Submitted filename: reponse_letter_R1.docx
Decision Letter - Gerardo Chowell, Editor, Nina H. Fefferman, Editor

Dear Mr. Zhao,

We are pleased to inform you that your manuscript 'Characterizing superspreading potential of infectious disease: Decomposition of individual transmissibility' has been provisionally accepted for publication in PLOS Computational Biology.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. 

Best regards,

Gerardo Chowell, PhD

Guest Editor

PLOS Computational Biology

Nina Fefferman

Deputy Editor

PLOS Computational Biology

Jason A. Papin

Editor-in-Chief

PLOS Computational Biology

Feilim Mac Gabhann

Editor-in-Chief

PLOS Computational Biology

***********************************************************

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: I thank the authors for addressing my previous comments. I am happy with the revision.

Reviewer #2: "Thus, if let the NB distribution have the same value...": The equation at the end of this sentence is very confusing and perhaps has a typo. k_D should be k_D hat? And equations need to be separated by commas; otherwise they look like a product.

Once this is corrected I believe the manuscript is ready to be published.

**********

Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: None

Reviewer #2: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Formally Accepted
Acceptance Letter - Gerardo Chowell, Editor, Nina H. Fefferman, Editor

PCOMPBIOL-D-21-01784R1

Characterizing superspreading potential of infectious disease: Decomposition of individual transmissibility

Dear Dr Zhao,

I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Zsofi Zombor

PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom ploscompbiol@plos.org | Phone +44 (0) 1223-442824 | ploscompbiol.org | @PLOSCompBiol

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .